Across TCGA pan-cancer cohorts, RNA5SP161 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP161’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where RNA5SP161 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP161 is over-expressed in tumor.
STAD and LUAD are the cancer types where RNA5SP161 tumor–normal differential expression is most reproducible.